Vaccine and Infectious Disease Division

About VIDD

Photo by Robert Hood / Fred Hutch News Service

A broad scope — laboratory, clinical and computational

The Vaccine and Infectious Disease Division (VIDD) was established as an institute in 2007 to facilitate and enhance the Hutch’s efforts in infectious disease prevention and vaccine development. The institute achieved division status in 2010 and currently has more than 50 faculty members. Collectively, VIDD integrates the latest in basic, computational and clinical research methods to advance the understanding of infectious disease processes.

VIDD is a diverse and active community of scientists that operates under a model of strong faculty governance — leadership oversees the routine functions of the division in consultation with the Executive Committee and receives recommended appointment and promotions changes from the Appointments and Promotions Committee and a Faculty Affairs Office implements the approved recommendations.

The environment of VIDD encourages creativity and innovation through the collaboration of diverse fields, and provides a unique and invaluable opportunity to utilize patient specimen repositories and data in biomedical research. Thus, the translational and multidisciplinary nature of VIDD is a true example of ‘bench to bedside’ science.   

VIDD labs utilize microbiology, biochemistry, and molecular and cellular biology methods to investigate the fundamental mechanisms underlying the pathobiology of infectious diseases. The goals of this basic science approach are to learn the key concepts of how the immune system works, how pathogens cause disease and to find ways of alleviating disease burden through preventive, diagnostic and therapeutic modalities including vaccine and drug development.

Computational biologists and biostatisticians accelerate our understanding of infectious diseases and public health via computational, statistical and mathematical modeling methods. We are home to the HIV Vaccine Trials Network (HVTN), the world’s largest clinical trials network for the development and testing of an HIV vaccine, and the Statistical Center for HIV/AIDS Research & Prevention (SCHARP).

A crucial and distinctive component of VIDD is the use of clinical research to reduce human infectious disease burden. Our faculty tackle this goal from many avenues: treatment, prevention, intervention and diagnostics. Many VIDD faculty also hold joint appointments with UW Medicine and SCCA and are involved in a number of clinical trials aimed at finding efficacious treatments and prevention strategies for diseases.

Global Reach

UCI-Fred Hutch Cancer Centre in Kampala.

Photo by Scott Rusch / Fred Hutch

VIDD research spans the globe, with laboratory, clinical and field sites in the Americas, Africa, Asia and Europe. The division has specific initiatives in Uganda, China and the Republic of South Africa to advance the understanding of infection-related cancers and infectious diseases that affect high-risk populations in these regions.

Our scientists around the world include clinicians, clinical trials specialists, statisticians, computational biologists and basic scientists taking pride in their collaborative efforts to predict, detect, treat and prevent infectious diseases in humans.